Regulatory report: Lithuania

Lithuania distinguishes cannabis and industrial hemp by the THC concentration of 0.2%. CBD extracts, full spectrum and finished products are not allowed on the market, but bill XIIIP-3195 (2) could legalise these products. This report offers a detailed analysis of the current regulatory framework in Lithuania and also discusses possible future regulation and how it might affect the current regime. The report covers all aspects of law including extracts, finished products, import and export rules, and medical and recreational cannabis.

Free Sample

Table of contents

  1. Executive Summary
  2. Hemp plant
  3. Extracts as finished product
  4. Finished products
  5. Import and export requirements
  6. Medical and recreational cannabis
  7. Relevant laws
  8. Relevant bodies

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information


Visit store

Check out our reports
available for purchase


Get a free sample of this report:

“ Regulatory report: Lithuania ”

    Buy report request information:

    “ Regulatory report: Lithuania ”

      Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.